California lawmakers react to federal ban on Medicaid funding for youth gender-affirming care
State legislators in California discussed the federal decision to stop Medicaid and CHIP payments for gender-affirming treatments for transgender minors.
California legislators met with The Center Square to evaluate the new federal rule that ends Medicaid and Children’s Health Insurance Program coverage for gender-affirming medical procedures for transgender youth. The Centers for Medicare and Medicaid Services said the change is based on evidence gaps and safety concerns, and it includes a six-month tapering period for hormone therapy while preserving mental-health care.
Assemblymember Christopher Ward described the policy as cruel and regressive, especially for low-income Californians, and warned it will create unequal access to needed care. In contrast, Assemblymember David Tangipa supported the decision, arguing that federal tax dollars should not fund elective surgeries for minors and that the state should follow scientific guidance. The rule is set to become effective on Oct. 13, and representatives from the federal agency and California health providers did not respond before publication.
Why it matters
The ruling could leave many transgender youths in California without affordable medical support for their transition.
In this story
